Business Context and Reporting Period
Company: Phibro Animal Health Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: May 6, 2025
Reporting Period: Event-based report regarding a corporate action announced on the filing date.
Key Financial Metrics
This filing does not contain comprehensive financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on a dividend declaration.
- Dividend Declaration: $0.12 per share on Class A and Class B common stock.
- Record Date: June 4, 2025.
- Payment Date: June 25, 2025.
Material Changes
The filing reports the declaration of a quarterly cash dividend. No other material changes to operations, financial condition, or capital structure are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the standard disclosure of the dividend payment schedule.
Investor Verification Checklist
- Verify the ex-dividend date (typically the trading day prior to the record date of June 4, 2025) to confirm eligibility for the $0.12 payment.
- Confirm the total number of outstanding Class A and Class B shares to estimate the aggregate cash outflow for the dividend.
- Review the attached press release (Exhibit 99.1) for any additional context regarding the dividend policy or capital allocation strategy.